Rachel Levine, assistant secretary of the Biden Department of Health and Human Services (HHS), criticized efforts in some states to ban minors from obtaining transgender drugs and surgeries, saying such bans constitute a “health equity issue.”
During an interview last week with NPR, transgender Levine said bills banning young people from accessing drugs, such as puberty blockers and cross-sex hormones, and transgender surgeries, such as elective double mastectomies, as well as bans against males competing in women’s sports are all “really challenging to see.”
Levine, born Richard Levine, said these transgender issues are not political, but very appropriate to address by one of the nation’s top health officials.
“I don’t see it as a political issue at all,” Levine said. “I view this as a health equity issue. This is about fairness and equality and about specifically health equity, which is part of my portfolio. So, I don’t see any risk in terms of politicization of this issue.”
In 2017, Levine delivered an address titled “It’s a Transgeneration: Issues in Transgender Medicine” to an audience at Franklin & Marshall College.
The former secretary of the Pennsylvania Department of Health, Levine said during remarks that those in the transgender medical industry who are seeing gender dysphoric teens from the “street,” living in homeless shelters, should not go through the usual procedure of first administering puberty blockers to stop normal puberty, but instead immediately prescribe cross-sex hormones.